Treatment of human papillomavirus gynecologic infections

Clinics in Laboratory Medicine

Volumn 20, Issue 2, 2000, Pages 407-422

  Auborn, K J ^a   Carter, T H ^a  

^a HPV Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FLUOROURACIL; IMIQUIMOD; PODOPHYLLIN; PODOPHYLLOTOXIN; RECOMBINANT ALPHA INTERFERON;

CLINICAL RESEARCH; CONDYLOMA; CRYOTHERAPY; DISEASE COURSE; GYNECOLOGIC INFECTION; HUMAN; LASER SURGERY; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; WART VIRUS;

EID: 0033934928     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0272-2712(18)30068-4     Document Type: Review

References (99)

1. Alvarez-Salas L.M. Cullinan A.E. Siwkowski A. Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes Proc Natl Acad Sei U S A 95 1998 1189
2. Apgar B.S. Changes in strategies for human papillomavirus genital disease Am Fam Physician 55 1997 1545
3. Arany I. Evans T. Tyring S.K. Tissue specific HPV expression and down regulation of local immune responses in condylomas from HIV seropositive individuals Sex Transm Infect 74 1998 349
4. Arany I. Rady P. Tyring S.K. Interferon treatment enhances the expression of underphosphorylated (biologically active) retinoblastoma protein in human papilloma virus-infected cells through the inhibitory TGF beta 1/IFN beta cytokine pathway Antiviral Res 23 1994 131
5. Arany I. Tyring S.K. Activation of local cell-mediated immunity in interferon-responsive patients with human papillomavirus-associated lesions J Interferon Cytokine Res 16 1996 453
6. Arany I. Yen A. Tyring S.K. p53, WAF1 / CIP1 and mdm2 expression in skin lesions associated with human papillomavirus and human immunodeficiency virus Anticancer Res 17 1997 1281
7. Arends M.J. Donaldson Y.K. Duvall E. Human papillomavirus type 18 associates with more advanced cervical neoplasia than human papillomavirus type 16 Hum Pathol 24 1993 432
8. Auborn K. Abramson A. Bradlow H.L. Estrogen metabolism and laryngeal papillomatosis: A pilot study on dietary prevention Anticancer Res 18 1998 4569
9. Backe J. Roos T. Kaesemann H. Local therapy and adjuvant interferon therapy in genital papilloma virus infections Gynakol Geburtshilfliche Rundsch 35 1995 79
10. Baken L.A. Koutsky L.A. Kuypers J. Genital human papillomavirus infection among male and female sex partners; prevalence and type-specific concordance J Infect Dis 171 1995 429
11. Baker C.C. Phelps W.C. Lingren V. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines J Virol 61 1987 962
12. Baker G.E. Tyring S.K. Therapeutic approaches to papillomavirus infections Dermatol Clin 15 1997 331
13. Barnes W. Woodworth C. Waggoner S. Rapid dysplastic transformation of human genital cells by human papillomavirus type 18 Gynecol Oncol 38 1990 343
14. Bauer H.M. Ting Y. Greer C.E. Genital human papilloma infection in female university students as determined by a PCR-based method JAMA 265 1991 472
15. Becker T.M. Stone K.M. Alexander E.R. Genital human papillomavirus infection: A growing concern Obstet Gynecol Clin North Am 14 1987 389
16. Beutner K.R. Ferenczy A. Therapeutic approaches to genital warts Am J Med 102 1997 28
17. Boshart M. Gissmann L. Ikenberg H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer EMBO J 3 1984 1151
18. Charuruks N. Voravud N. Termrungruanglert W. 13-cis-retinoic acid and interferon-alpha 2a therapy in locally advanced squamous cell carcinoma of the cervix: p53 alteration, proliferating cell nuclear antigen expression and angiogenesis response J Obstet Gynacol Res 24 1998 335
19. Chen Z. Kamath P. Zhang S. Effects on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavirus type 18 Cancer Gene Ther 3 1996 18
20. Clark P.R. Roberts M.L. Cowsert L.M. A novel drug screening assay for papillomavirus specific antiviral activity Antiviral Res 37 1998 97
21. Coll D.A. Rosen C.A. Auborn K. Treatment of recurrent respiratory papillomatosis with indole-3-carbinol Am J Otolaryngol 18 1997 283
22. Cover C.M. Hsieh S.J. Tran S.H. Indole-3-carbinol inhibits the expression of cyclindependent kinase-6 and induces G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling J Biol Chem 273 1998 3838
23. Daling J.R. Sherman K.J. Weiss N.S. Risk factors for condyloma acuminatum in women Sex Transm Dis 13 1986 16
24. DeVilliers E-M Gissman L. zur Hausen H. Molecular cloning of viral DNA from human genital warts J Virol 40 1981 932
25. Durst M. Gissmann L. Ikenberg H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions Proc Natl Acad Sei U S A 80 1983 3812
26. Dyson N. Howley P.M. Munger K. The human papilloma-virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product Science 243 1989 934
27. 2 therapy in female HPV genitalis Minerva Ginecol 48 1996 345
28. Ge X. Yannai S. Rennert G. 3,3’-Diindolylmethane induces apoptosis in human cancer cells Biochem Biophys Res Commun 228 1996 153
29. Giandomenico V. Vaccari G. Fiorucci G. Apoptosis and growth inhibition of squamous carcinoma cells treated with interferon-alpha, IFN-beta and retinoic acid are associated with induction of the cyclin-dependent kinase inhibitor p21 Eur Cytokine Netw 9 1998 619
30. Gissmann L. Schwarz E. Persistence and expression of human papillomavirus DNA in genital cancer Everd D. Clark S. Papillomaviruses 1986 John Wiley Chichester 190
31. Gissmann L. Wolnik L. Ikenberg H. Human papillomavirus type 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers Proc Natl Acad Sei U S A 80 1983 560
32. Gissmann L. zurHausen H. Partial characterization of viral DNA from human genital warts (condylomata acuminata) Int J Cancer 25 1980 605
33. Goodman M.T. Kiviat N. McDuffie K. The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii Cancer Epidemiol Biomarkers Prev 7 1998 537
34. Gross G. Therapy of human papillomavirus infection and associated epithelial tumors Intervirol 40 1997 368
35. Gross G. Von Krogh G. Therapy of anogenital HPV-induced lesions Clin Dermatol 15 1997 457
36. Hagensee M.E. Progress in the development of HPV vaccines Infect Med 14 1997 555
37. Hatch K.D. Clinical appearance and treatment strategies for human papillomavirus: A gynecologic perspective Am J Obstet Gynecol 172 1995 1340
38. He Y. Huang L. Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter Cancer Res 57 1997 3993
39. Ho G.Y. Palan P.R. Basu J. Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia Int J Cancer 78 1998 594
40. Horner M. Interferon in anogenital infections with human papillomavirus Wien Med Wochenschr 143 1993 464
41. Howett M.K. Neely E.B. Christensen N.D. A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses Antimicrob Agents Chemother 43 1999 314
42. Ikeda M. Noda K. Hiura M. Late phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical cancer. ETP 21 Study Group—Cervical Cancer Group Jpn J Cancer Chemother 25 1998 2249
43. Jenson A.B. Lancaster W.D. Association of human papillomavirus with benign, prema-lignant, and malignant anogenital lesions Pfister H. Papillomaviruses and Human Cancer 1990 CRC Boca Raton 11
44. Jin L. Qi M. Chen D-Z Indole-3-carbinol prevents cervical cancer in HPV16 transgenic mice Cancer Res 59 1999 1693
45. Johnson J.A. Gangemi J.D. Selective inhibition of human papillomavirus-induced cell proliferation by (S)-l-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine Antimicrob Agents Chemother 43 1999 1198
46. Kavanagh J.J. Verschraegen C.F. Kudelka A.P. Irinotecan in cervical cancer Oncology (Huntingt) 12 8 suppl 6 1998 94
47. Kelloff G.V. Crowell J.A. Hawk E.T. Strategy and planning for chemopreventative drug development plans II J Cell Biochem 26S 1996 54
48. Kenney J.W. Comparison of risk factors, severity, and treatment of women with genital HPV Cancer Nurs 17 1994 308
49. Keys H.M. Bundy B.N. Stehman F.B. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154
50. Klutke J.J. Bergman A. Interferon as an adjuvant treatment for genital condyloma acuminatum Int J Gynaecol Obstet 49 1995 171
51. Kwasniewska A. Charzewska J. Tukendorf A. Dietary factors in women with dysplasia colli uteri associated with human papillomavirus infection Nutr Cancer 30 1998 39
52. Kwasniewska A. Tukendorf A. Semczuk M. Frequency of HPV infection and GSH levels in plasma of women with cervical dysplasia Eur J Gynaecol Oncol 18 1997 196
53. Lacey C.J. Thompson H.S. Monteiro E.F. Phase Ila. safety and immunogenicity of a therapeutic vaccine, लA-GW in persons with genital warts J Infect Dis 179 1999 612
54. Linnehan M.J. Andrews S. Groce N.E. College health providers’ knowledge, attitudes, and management practices of genital HPV infection Nurse Pract 21 1996 122
55. Liu H. Wormke M. Safe S.H. Indolo[3,2-b]carbazole: A dietary derived factor that exhibits both antiestrogenic and estrogenic activity J Natl Cancer Inst 86 1994 1758
56. Lorincz A.T. Lancaster W.D. Temple G.F. Cloning and characterization of a new type of human papilloma virus from a woman with dysplasia of the uterine cervix J Virol 58 1986 225
57. Lowy D.R. Schiller J.T. Papillomaviruses: prophylactic vaccine prospects Biochim Biophys Acta 1423 1999 M1
58. Lutzner V.A. Blanchet-Bardon C. Orth G. Clinical observations, virologic studies and treatment trials in patients with epidermodysplasia-verruciformis, a disease induced by specific human papillomaviruses J Invest Dermatol 198 1984 83s
59. Maehama T. Patzelt A. Lengert M. Selective down-regulation of human papillomavirus transcription by 2-deoxyglucose Int J Cancer 76 1998 639
60. Markowska J. Nowak M. Niecewicz R. Results of topical treatment of HPV infection in the uterine cervix using interferon beta, 13-cis-retinoic acid and TFX Eur J Gynaecol Oncol 15 1994 65
61. Miller D.M. Brodell R.T. Human papillomavirus infection: Treatment options for warts Am Fam Physician 53 1996 135
62. Morris M. Eifel P.J. Lu J. Pelvic radiation with concurrent chemotherapy compared with pelvic and par-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137
63. Mounts P. Shah K.V. Respiratory papillomatosis: Etiological relation to genital tract papillomaviruses Prog Med Virol 29 1984 90
64. Mundt A.J. Rotmensch J. Waggoner S. Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies Gynecol Oncol 72 1999 45
65. Noda K. Tanaka K. Ozaki M. Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group—Cervical-Ovarian Cancer Group Jpn J Cancer Chemother 25 1998 2061
66. Okamoto A. Woodworth C.D. Yen K. Combination therapy with podophyllin and vidarabine for human papillomavirus positive cervical intraepithelial neoplasia Oncol Rep 6 1999 269
67. Paavonen J. Koutsky L.A. Kiviat N. Cervical neoplasia and other STD-related genital and anal neoplasias Holmes K.K. Mardh P.A. Sparling P.G. (eds): Sexually Transmitted Diseases ed 2 1990 McGraw Hill New York 561
68. Pfister H. The role of human papillomavirus in anogenital cancer Obstet Gynecol Clin North Am 23 1996 579
69. Phelps W.C. Barnes J.A. Lobe D.C. Molecular targets for human papillomaviruses: Prospects for antiviral therapy Antiviral Chem Chemother 9 1998 359
70. Quick C.A. Watts S.L. Krzyzek R.A. Relationship between condylomata and laryngeal papillomata. Clinical and molecular virological evidence Ann Otol Rhinol Laryngol 89 1980 467
71. Rando R.F. Human papillomavirus: Implications for clinical medicine Ann Intern Med 108 1986 628
72. Rao G.N. Influence of diet on tumors of hormonal tissues Prog Clin Biol Res 394 1996 41
73. Rose P.G. Bundy B.N. Watkins E.B. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cancer N Engl J Med 340 1999 1144
74. Rosen C.A. Woodson G.E. Thompson J.W. Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis Otolaryngol Head Neck Surg 118 1998 810
75. Schafer K. Muller M. Faath S. Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: Induction of cytotoxic T cells and specific tumor protection Int J Cancer 81 1999 881
76. Schneider A, Koutsky LA: Natural history and epidemiology features of genital HPV infection. In Munoz N, Bosch FX, Shah KV et al. (eds): The Epidemiology of Human Papillomavirus and Cervical Cancer. Lyon, 1992, p 25 IARC
77. Schneider A. Kraus H. Schuhmann R. Papillomavirus infection of the lower genital tract: Detection of viral DNA in gynecological swabs Int J Cancer 35 1985 443
78. Schneider A. Meinhardt G. Kirchmayr R. Prevalence of human papillomavirus genomes in tissues from the lower genital tract as detected by molecular in situ hybridization Int J Gynecol Pathol 10 1991 1
79. Schneider A. Shah K. The role of vitamins in the etiology of cervical neoplasia: An epidemiological review Arch Gynecol Obstet 246 1989 1
80. Schon H.J. Grgurin M. Szekeres T. A new mode of treatment of human papilloma virus associated anogenital lesions using a nonsteroid estrogen analogue Wien Klin Wochenschr 108 1996 45
81. Shadan F.F. Cowsert L.M. Villarreal L.P. n-Butyrate, a cell cycle blocker, inhibits the replication of polyomaviruses and papillomaviruses but not that of adenoviruses and herpesviruses J Virol 68 1994 4785
82. Snoeck R. Wellens W. Desloovere C. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-l-(3-hydroxy-2-phosphonylmethoxypro-pyl)cytosine] J Med Virol 54 1998 219
83. Spitzer M. Lower genital tract intraepithelial neoplasia in HIV-infected women: Guidelines for evaluation and management Obstet Gynecol Surv 54 1999 131
84. Spitzer M. Krumholz B.A. Human papillomavirus-related diseases in the female patient Urol Clin North Am 19 1992 71
85. Spitzer M. Krumholz B.A. Chernys A.E. Comparative utility of repeat Papanicolaou smears, cervicography, and colposcopy in the evaluation of atypical Papanicolaou smears Obstet Gynecol 69 1987 731
86. Stone K.M. Human papillomavirus infection and genital warts: Update on epidemiology and treatment Clin Infect Dis 20 suppl 1 1995 S91
87. Syrjanen K.J. Papillomavirus infections and cancers Syrrjanen K. Gissmann L. Koss L.G. Papillomaviruses and Human Disease 1987 Springer New York 467
88. Telang N.T. Katdare M. Bradlow H.L. Inhibition of proliferation and modulation of estrogen metabolism: Novel mechanisms for breast cancer prevention by the phytochemical indole-3-carbinol Proc Soc Exp Biol Med 216 1997 246
89. Thompson H.S. Davies M.L. Holding F.P. Phase I safety and antigenicity of लA-GW: A recombinant HPV6 L2E7 vaccine for the treatment of genital warts Vaccine 17 1999 40
90. Tindle R.W. Immunmanipulative strategies for the control of human papillomavirus associated cervical disease Immunol Res 16 1997 387
91. VanDriel W.J. Ressing M.E. Brandt R.M. The current status of therapeutic HPV vaccine Ann Med 28 1996 471
92. Venturini F. Braspenning J. Homann M. Kinetic selection of HPV 16 E6/E7-directed antisense nucleic acids: Anti-proliferative effects on HPV 16-transformed cells Nucleic Acids Res 27 1999 1585
93. Verdon M.E. Issues in the management of human papillomavirus genital disease Am Fam Physician 55 1997 1545
94. Werness B.A. Levine A.J. Howley P.M. Association of human papillomavirus type 16 and 18 E6 proteins with p53 Science 248 1990 76
95. Yee C. Krishnan-Hewlett Z. Baker C.C. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines Am J Pathol 119 1985 361
96. Yuan F. Chen D-Z Liu K. Anti-estrogenic activities of indole-3-carbinol in cervical cells: Implication for prevention of cervical cancer Anticancer Res 19 1999 1673
97. Zabawski E.J. Jr Cockerell C.J. Topical and intralesional cidofovir: A review of pharmacology and therapeutic effects J Am Acad Dermatol 39 1998 741
98. Zarcone R. Bellini P. Carfora E. Therapeutic protocol of vulvar and cervical HPV-infection Clin Exp Obstet Gynecol 24 1997 93
99. zur Hausen H. Schneider A. The role of papillomaviruses in human anogenital cancers Salzman N.P. Howley P.M. The Papovaviridae ed 2 1987 Plenum Press New York 245